Park, Soo-Yeon
Jung, Min-young
Nguyen, Cong Duc
Article History
Received: 14 February 2025
Accepted: 2 March 2026
First Online: 9 March 2026
Declarations
:
: This trial will abide by the Declaration of Helsinki and other ethical guidelines. This trial was approved by the Institutional Review Board of Naju Dongshin University Korean Medicine Hospital (approval no. NJ-IRB-24-8). The trial protocol, using an investigational medical device, was reviewed and approved by the Ministry of Food and Drug Safety of the Republic of Korea. This study was registered with the Clinical Research Information Service of the Republic of Korea (registration no. KCT0009870) on 25 October 2024. All participants will receive sufficient information before deciding to participate in this trial and will voluntarily submit written consent.
: Not applicable.
: The authors declare no competing interests.